We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Megadyne and Ethicon Combine Energy Device Portfolio

By HospiMedica International staff writers
Posted on 10 Dec 2013
Megadyne Medical Products (Draper, UT, USA), a leading developer, manufacturer, and supplier of electrosurgical products, has announced that it has entered into a collaboration agreement with Ethicon Endo-Surgery (Ethicon; Cincinnati, OH, USA). More...


Under the terms of the agreement, both Megadyne and Ethicon will offer customers a broadened variety of energy solutions across multiple energy platforms, simplifying inventory management, as well as offering increased value through flexible contracting solutions, capital trade-out programs, product and supplier standardization, and environmentally friendly solutions. The combined portfolio will include monopolar and standard bipolar solutions from Megadyne and advanced bipolar and ultrasonic energy solutions from Ethicon.

“Megadyne is proud to collaborate with Ethicon, as we share a common vision and commitment to providing high-quality, world-class health care products to our customers,” said Robert Farnsworth, CEO of Megadyne Medical Products. “This agreement will enable us to jointly leverage each of our strengths and expertise to provide a comprehensive portfolio of solutions across the spectrum of energy platforms.”

“Our companies share a common vision to advance surgery and improve patient outcomes through high quality standards, intuitive to use products and a customer solutions mindset,” said Michelle Brennan, worldwide president for the Ethicon Energy business. “Now leveraging our combined scope and scale, we can provide a comprehensive portfolio of solutions across the spectrum of energy platforms.”

Related Links:

Megadyne Medical Products
Ethicon Endo-Surgery



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Dual Chamber Warming Cabinet
D-Series
New
Pocket Fetal Doppler
CONTEC10C/CL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.